A study proposes that vitamin shots may avert severe long-term disability in multiple sclerosis patients. Presently there is no adequate treatment for the chronic progressive phase of MS.

The study results showed that there was a decrease in nerve degeneration in mice with MS-type symptoms when they were given a form of vitamin B3 called nicotinamide

A study finds that vitamin shots may prevent long-term disability in multiple sclerosis patients.

Scientists have not yet found an effective treatment for the chronic progressive state of MS, when serious disability most commonly occurs.

In the Children's Hospital Boston study, researchers gave mice a form of vitamin B3 called nicotinamide. This treatment reduced the risk of nerve degeneration in mice with MS-like symptoms